twoplus fertility vs GE HealthCare
Side-by-side comparison of AI visibility scores, market position, and capabilities
Singapore at-home fertility applicator for natural conception avoiding costly IVF/IUI; YC S20 $5.3M Monk's Hill Ventures-backed revenue-generating 2024 in SG/UK/US competing with Mosie Baby and Natalist for consumer fertility health products.
About
Twoplus Fertility is a Singapore-based consumer fertility health company — backed by Y Combinator (S20) with $5.3 million raised including a $5.15 million seed round led by Monk's Hill Ventures in May 2022 — providing couples experiencing difficulty conceiving with at-home fertility products designed as non-invasive, affordable alternatives to clinical fertility treatments, starting with the Twoplus Sperm Guide applicator (an at-home cervical cap applicator that positions sperm closer to the cervix during natural conception attempts, increasing the probability of fertilization for couples with mild male factor infertility or unexplained subfertility). Founded in 2019 by Prusothman Raja and Benjamin Tee, Twoplus became revenue-generating in 2024 and distributes products in Singapore, the United Kingdom, and the United States.
Chicago medical imaging and AI diagnostics (NASDAQ: GEHC) ~$19.7B FY2024 revenue; GE spinoff Jan 2023, Edison AI 100+ models, 4M+ installed devices, Alzheimer's PET tracer competing with Siemens Healthineers.
About
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designing, manufacturing, and servicing medical imaging systems, patient monitoring equipment, pharmaceutical diagnostics, and AI-powered clinical decision support software through approximately 51,000 employees in 160 countries. GE HealthCare was spun off from General Electric Company in January 2023 — one of the most significant healthcare demergers in history — and has operated as an independent public company building its own capital structure, R&D investment priorities, and operational identity separate from GE's industrial conglomerate structure. In fiscal year 2024, GE HealthCare reported revenues of approximately $19.7 billion, with its four business segments contributing: Imaging (MRI, CT, X-ray, molecular imaging — ~$9.1B), Ultrasound (~$3.0B), Patient Care Solutions (monitoring, anesthesia — ~$3.6B), and Pharmaceutical Diagnostics (PET/SPECT contrast agents — ~$2.6B). CEO Peter Arduini has prioritized accelerating GE HealthCare's AI integration across its imaging portfolio — the Edison AI platform (100+ AI models cleared or in development for radiology workflows) embeds AI-assisted detection, workflow optimization, and image quality enhancement into GE HealthCare scanners, positioning the company as a digital health platform rather than a hardware manufacturer.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.